Clinitech Laboratory Ltd Receives Letter from Promoter under SEBI SAST Regulations for FY 2025-2026

Clinitech Laboratory Ltd has received a yearly disclosure under regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeover) Regulation, 2011, as amended, from the Promoter & Promoters Group of the Company for the year ended on 31st March, 2026. The promoter, Mr. Jagdish Nayak, held 7,22,500 equity shares of the Company as on March 31, 2026. However, he acquired an additional 9,600 equity shares on March 30, 2026, which were reflected in the BENPOS on April 1, 2026. The company confirms that no encumbrance was made over the shares held by them directly or indirectly during the financial year ended March 31, 2026. All requisite disclosures have been filed with the relevant authorities within the prescribed time limit.